Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.
Tahoe Therapeutics has raised $30.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.
Tahoe Therapeutics's investors include General Catalyst, AIX Ventures, Wing Venture Capital, Conviction, Civilization Ventures.
Tahoe Therapeutics is headquartered in South San Francisco, United States.
Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.
Tahoe Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tahoe Therapeutics — Funding & Investors." VCBacked, August 11, 2025, https://www.vcbacked.co/company/tahoe-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Tahoe Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tahoe-therapeutics
{{cite web |title=Tahoe Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tahoe-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated